Lichter Jay's Form 4 filing
Janux Therapeutics, Inc. (JANX) · filed Sep 12, 2024
- Accession no.
- 0001415889-24-023337
- Filed
- Sep 12, 2024, 8:42 PM ET
- Trade date
- Sep 10-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $21.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lichter JayCIK 0001376355 | 10% Owner |
| Avalon Ventures XI, L.P.CIK 0001652901 | 10% Owner |
| Avalon BioVentures SPV I, L.P.CIK 0001844550 | 10% Owner |
| Avalon BioVentures I, LPCIK 0001873935 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Common Stock | SSaleDisposed | −11,319 | $46.13 | −$522,145.47 | 3,151,532 | Direct | |
| Sep 10, 2024 | Common Stock | SSaleDisposed | −2,193 | $46.13 | −$101,163.09 | 610,489 | Indirect | |
| Sep 10, 2024 | Common Stock | SSaleDisposed | −11,557 | $46.13 | −$533,124.41 | 3,217,817 | Indirect | |
| Sep 10, 2024 | Common Stock | SSaleDisposed | −34,326 | $46.66 | −$1,601,651.16 | 3,117,206 | Direct | |
| Sep 10, 2024 | Common Stock | SSaleDisposed | −6,649 | $46.66 | −$310,242.34 | 603,840 | Indirect | |
| Sep 10, 2024 | Common Stock | SSaleDisposed | −35,047 | $46.66 | −$1,635,293.02 | 3,182,770 | Indirect | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −158,031 | $47.00 | −$7,427,457 | 2,959,175 | Direct | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −30,613 | $47.00 | −$1,438,811 | 573,227 | Indirect | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −161,356 | $47.00 | −$7,583,732 | 3,021,414 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.